Table 3.
Characteristics of Study Participants (N = 10)
| M | SD | n | % | |
|---|---|---|---|---|
| Age | 15.2 | 1.2 | ||
| Sex (female/male) | 7/3 | 70 | ||
| Background | ||||
| White | 4 | 40 | ||
| African-American/Black | 1 | 10 | ||
| Hispanic | 4 | 40 | ||
| Other | 1 | 10 | ||
| Medications | 1.2 | 1.0 | ||
| Antidepressant | 5 | 50 | ||
| Antipsychotic | 1 | 10 | ||
| Anxiolytic | 2 | 20 | ||
| Mood Stabilizer | 3 | 30 | ||
| Stimulant | 1 | 10 | ||
| None | 3 | 30 | ||
| Mental Health Syndromes/Diagnoses | 2.4 | 0.7 | ||
| At-Risk Mental Health Conditiona | ||||
| Psychosis-Risk Syndrome | 7 | 70 | ||
| Unspecified Bipolar Disorder | 3 | 30 | ||
| Comorbid Psychiatric Conditions | ||||
| Attention-Deficit Hyperactivity Disorder | 3 | 30 | ||
| Autism Spectrum Disorder | 1 | 10 | ||
| Generalized Anxiety Disorder | 3 | 30 | ||
| Major Depressive Disorder | 6 | 60 | ||
| Oppositional Defiant Disorder | 1 | 10 | ||
| Social Anxiety Disorder | 2 | 20 | ||
| Trichotillomania | 1 | 10 |
a
To be eligible for the treatment, participants were required to meet criteria for a psychosis-risk syndrome or an unspecified bipolar diagnosis.